| 摘要 |
This invention relates to 2-arylimino heterocycles, including 2-arylimino-1, 3-thiazolidines, 2-arylimino-2, 3, 4, 5-tetrahydro-1, 3-thiazines, 2-arylimino-1, 3-thiazolidin-4-ones, 2-arylimino-1, 3-thiazolidin-5-ones, and 2-arylimino-1, 3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
|
| 申请人 |
BAYER CORPORATION |
发明人 |
DIXON, BRIAN, R.;BAGI, CEDO, M.;BRENNAN, CATHERINE, R.;BRITTELLI, DAVID, R.;BULLOCK, WILLIAM, H.;CHEN, JINSHAN;COLLIBEE, WILLIAM, L.;DALLY, ROBERT;JOHNSON, JEFFREY, S.;KLUENDER, HAROLD, C., E.;LATHROP, WILLIAM, F.;LIU, PEIYING;MASE, CAROL, ANN;REDMAN, ANIKO, M.;SCOTT, WILLIAM, J.;URBAHNS, KLAUS;WOLANIN, JOHN, J. |
